I1877
异柠檬脱氢酶 (NADP) 来源于猪心脏
Type I, 0.5-3.0 unit/mg solid (plus numerous enzyme activities associated with porcine heart)
别名:
ICDH, IDH, 苏式-Ds-异柠檬酸: NADP+ 氧化还原酶
登录 查看组织和合同定价。
选择尺寸
关于此项目
化学文摘社编号:
UNSPSC Code:
12352204
NACRES:
NA.54
EC Number:
232-835-3
MDL number:
Specific activity:
0.5-3.0 unit/mg solid (plus numerous enzyme activities associated with porcine heart)
Biological source:
Porcine heart
产品名称
异柠檬脱氢酶 (NADP) 来源于猪心脏, Type I, 0.5-3.0 unit/mg solid (plus numerous enzyme activities associated with porcine heart)
biological source
Porcine heart
type
Type I
form
solid
specific activity
0.5-3.0 unit/mg solid (plus numerous enzyme activities associated with porcine heart)
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Analysis Note
粗品
Biochem/physiol Actions
Isocitrate dehydrogenase (IDH) plays a major role in the Krebs cycle by catalyzing the oxidative decarboxylation of isocitrate. The oxidative decarboxylation of isocitrate generates α-ketoglutarate and NADPH. NADPH produced is essential for the production of fatty acids and cholesterol. This NADP-dependent molecules serves as homodimers.
Other Notes
One unit will convert 1.0 μmole of isocitrate to α-ketoglutarate per min at pH 7.4 at 37°C.
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
低风险生物材料
此项目有
The Molecular Pathogenesis of Glioblastoma
Glioblastoma, 21-31 (2016)
Molecular Testing for Glioblastoma
Diagnostic Molecular Pathology, 339-347 (2017)
Chapter One - Mechanisms of Epigenetic Regulation of Leukemia Onset and Progression
Ntziachristos P, et al.
Advances in Immunology, 117, 1-38 (2013)
Omar Abdel-Wahab et al.
Hematology. American Society of Hematology. Education Program, 2012, 56-64 (2012-12-13)
The myelodysplastic syndromes (MDS) are a clinically and cytogenetically heterogeneous group of clonal diseases characterized by ineffective hematopoiesis, peripheral blood cytopenias, and an increased risk of progression to acute myeloid leukemia. The precise molecular mechanisms behind the development of MDS
Maria Paola Martelli et al.
Blood reviews, 27(1), 13-22 (2012-12-25)
Acute myeloid leukemia (AML) is a molecularly heterogeneous disease. Based on cytogenetics and FISH, AML patients are stratified into three major risk categories: favourable, intermediate and unfavourable. However, prognostic stratification and treatment decision for the intermediate risk category, that mostly
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持